These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12036653)

  • 41. The clinical study of Healon 5 in phacoemulsification and IOL implantation.
    Yang H; Zheng D; Huang J; Huang Y; Zhang Z
    Yan Ke Xue Bao; 2001 Sep; 17(3):186-90. PubMed ID: 12567750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of the soft-shell technique in patients with Fuchs' endothelial dystrophy.
    Tarnawska D; Wylegała E
    J Cataract Refract Surg; 2007 Nov; 33(11):1907-12. PubMed ID: 17964396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: experimental model.
    Belda JI; Artola A; García-Manzanares MD; Ferrer C; Haroun HE; Hassanein A; Baeyens V; Munoz G; Alió JL
    J Cataract Refract Surg; 2005 Jun; 31(6):1213-8. PubMed ID: 16039500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraocular pressure after small incision cataract surgery with Healon5 and Viscoat.
    Rainer G; Menapace R; Findl O; Georgopoulos M; Kiss B; Petternel V
    J Cataract Refract Surg; 2000 Feb; 26(2):271-6. PubMed ID: 10683797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corneal thickness and visual acuity after phacoemulsification with 3 viscoelastic materials.
    Davis EA; Lindstrom RL
    J Cataract Refract Surg; 2000 Oct; 26(10):1505-9. PubMed ID: 11033398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trial evaluating Viscoat and Visthesia ophthalmic viscosurgical devices in corneal endothelial loss after cataract extraction and intraocular lens implantation.
    Papaconstantinou D; Karmiris T; Diagourtas A; Koutsandrea C; Georgalas I
    Cutan Ocul Toxicol; 2014 Sep; 33(3):173-80. PubMed ID: 24156304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical results of phacoemulsification with the use of Healon5 or Viscoat.
    Tetz MR; Holzer MP; Lundberg K; Auffarth GU; Burk RO; Kruse FE
    J Cataract Refract Surg; 2001 Mar; 27(3):416-20. PubMed ID: 11255054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alteration of free radical development by ophthalmic viscosurgical devices in phacoemulsification.
    Takahashi H; Suzuki H; Shiwa T; Sakamoto A
    J Cataract Refract Surg; 2006 Sep; 32(9):1545-8. PubMed ID: 16931270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the clinical performance of Healon 5 and Healon in phacoemulsification.
    Cavallini GM; Campi L; Delvecchio G; Lazzerini A; Longanesi L
    Eur J Ophthalmol; 2002; 12(3):205-11. PubMed ID: 12113566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative method to determine the cohesion of viscoelastic agents by dynamic aspiration.
    Poyer JF; Chan KY; Arshinoff SA
    J Cataract Refract Surg; 1998 Aug; 24(8):1130-5. PubMed ID: 9719975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formation of free radicals during phacoemulsification.
    Holst A; Rolfsen W; Svensson B; Ollinger K; Lundgren B
    Curr Eye Res; 1993 Apr; 12(4):359-65. PubMed ID: 8391415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative evaluation of efficacy and safety of ophthalmic viscosurgical devices in phacoemulsification [ISRCTN34957881].
    Vajpayee RB; Verma K; Sinha R; Titiyal JS; Pandey RM; Sharma N
    BMC Ophthalmol; 2005 Jul; 5():17. PubMed ID: 16018819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of sodium hyaluronate, chondroitin sulfate, and methylcellulose on the corneal endothelium and intraocular pressure.
    Mac Rae SM; Edelhauser HF; Hyndiuk RA; Burd EM; Schultz RO
    Am J Ophthalmol; 1983 Mar; 95(3):332-41. PubMed ID: 6402935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corneal endothelial cell protection during phacoemulsification: low- versus high-molecular-weight sodium hyaluronate.
    Miyata K; Maruoka S; Nakahara M; Otani S; Nejima R; Samejima T; Amano S
    J Cataract Refract Surg; 2002 Sep; 28(9):1557-60. PubMed ID: 12231310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of thermoreversible hydrogel (poloxamer 407) to protect the corneal endothelium during phacoemulsification in porcine and rabbit eyes.
    Choi JY; Cho CS; Han YK
    J Cataract Refract Surg; 2018 Oct; 44(10):1254-1260. PubMed ID: 30139637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Completion rate of continuous curvilinear capsulorhexis in pediatric cataract surgery using different viscoelastic materials.
    Jeng BH; Hoyt CS; McLeod SD
    J Cataract Refract Surg; 2004 Jan; 30(1):85-8. PubMed ID: 14967272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of viscoelastic substances on the corneal endothelium during cataract surgery by phacoemulsification.
    Adina B
    Oftalmologia; 2008; 52(1):84-9. PubMed ID: 18714496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retained Viscoat and intraocular pressure after phaceomulsification.
    Watts P; Austin M
    Indian J Ophthalmol; 1999 Dec; 47(4):237-40. PubMed ID: 10892480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Viscoelastic substances in cataract surgery. Principles and current overview].
    Hessemer V; Dick B
    Klin Monbl Augenheilkd; 1996; 209(2-3):55-61. PubMed ID: 8992084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of hyaluronidase in reducing increases in intraocular pressure related to the use of viscoelastic substances.
    Harooni M; Freilich JM; Abelson M; Refojo M
    Arch Ophthalmol; 1998 Sep; 116(9):1218-21. PubMed ID: 9747683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.